Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kim W. Benner"'
Autor:
Edward P. Acosta, Megan Smith, Hector H. Gutierrez, Luz Helena Gutierrez Sanchez, Kevin J. Ryan, Jennifer S. Guimbellot, Janaina Nogueira Anderson, Kim W. Benner
Publikováno v:
J Cyst Fibros
The CFTR modulator combination elexacaftor/tezacaftor/ivacaftor (ETI) is a genetic mutation-targeted treatment in cystic fibrosis that results in profound improvements in clinical outcomes. Each of the compounds are substrates of CYP3A4/5, the cytoch
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE Vancomycin is commonly used in the neonatal population to treat Gram-positive bacterial infections. Despite frequent use, consensus on the ideal dosing regimen in low birth weight (LBW) neonates is lacking. The objective of this research is
Autor:
Kim W. Benner, Brad Troxler, Heather Searcy, Carly Crowder, April Yarbrough, Joshua W Branstetter
Publikováno v:
Pediatric Pulmonology. 55:3337-3342
INTRODUCTION Respiratory infection with methicillin-resistant Staphylococcus aureus (MRSA) is an increasing complication in cystic fibrosis (CF) that results in accelerated lung function decline and mortality. Vancomycin is considered a first-line in
Autor:
Amy L. Potts, Kim W. Benner, Rachel Meyers, Melissa K. Heigham, Lea S. Eiland, Karl F. Gumpper, Katherine Pham
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 23:177-191
The purpose of these guidelines is to assist pharmacists and pharmacy departments in meeting the special needs of pediatric patients in hospitals and health systems. Pharmacists encounter numerous challenges when providing care to pediatric patients,
Autor:
Shannon A. Ross, Kathleen R. Richard, Sara Oliver, Kim W. Benner, Joshua J. Lovvorn, Michele Kong
Publikováno v:
The American Journal of Case Reports
Patient: Male, 11 Final Diagnosis: Chromobacterium violaceum infection Symptoms: Abscess • fever • rash Medication: — Clinical Procedure: ECMO Specialty: Critical Care Medicine Objective: Rare disease Background: Chromobacterium violaceum (C. v
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 19:83-90
OBJECTIVES: To determine the proportion of infections caused by extended-spectrum ß-lactamase (ESBL)–producing Klebsiella or Escherichia coli Gram-negative organisms in the pediatric intensive care unit (PICU), and to identify risk factors for the
Autor:
J. Lynn Zinkan, Mary A. Worthington, Amber Q. Youngblood, Jennifer Beall, Brenda Denson, Kim W. Benner, Nancy M. Tofil, Mary Grace Cravens
OBJECTIVES: The purpose of this study was to evaluate the difference between education via written materials alone and written materials enhanced with hands-on simulation. METHODS: A simulation case, educational module, and assessment regarding torsa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5957e2ba0576b7d5abc4b1b9d400a872
https://europepmc.org/articles/PMC5178809/
https://europepmc.org/articles/PMC5178809/
Autor:
Marjorie Lee White, Brian Michael Varisco, Kim W. Benner, Nancy M. Tofil, Jeffrey A. Alten, Lynn Zinkan
Publikováno v:
Journal of Graduate Medical Education. 3:81-87
ObjectiveTrue pediatric emergencies are rare. Because resident work hours are restricted and national attention turns toward patient safety, teaching methods to improve physician performance and patient care are vital. We hypothesize that a critical-
Publikováno v:
Southern Medical Journal. 98:253-256
The authors describe a case of fatal hypermagnesemia caused by an Epsom salt enema. A 7-year-old male presented with cardiac arrest and was found to have a serum magnesium level of 41.2 mg/dL (33.9 mEq/L) after having received an Epsom salt enema ear